Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes
Completed · Not applicable
Conditions studied: Diabetes Type 2
In brief
To evaluate the effect of onyx sorghum on blood glucose levels in patients with type 2 diabetes (T2DM).
Key facts
- Study ID
- NCT03714451
- Run by
- Yale University
- People needed
- 24
- Starts
- 2018-11-01
- Expected to finish
- 2022-12-30
- Last updated by the study team
- 2023-02-14
Who can join
Age: 30 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Ages 30-65 years
- A1c < 8.5%
- BMI > 18.5
You may not qualify if…
- known malignancy, anemia, kidney disease, and/or liver disease
- untreated thyroid disease
- uncontrolled hypertension
- initiation of any anti-diabetes medications within the last 3 months
- greater than 5% change in weight in the last 3 months
- current or recent steroid use in the last 3 months
- for women: pregnancy or breastfeeding
Where it is running
- Yale New Haven Hospital — New Haven, Connecticut, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- Yale Center for Clinical Investigation — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.